Role of circular RNA in neurological disease

Role of circular RNA in neurological disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografiset tiedot
Päätekijä:	Salsabil, Labiba
Muut tekijät:	Chowdhury, Namara Mariam
Aineistotyyppi:	Opinnäyte
Kieli:	English
Julkaistu:	Brac University 2024
Aiheet:	Circular RNA circRNA Neurological disorder Alzheimer’s disease Parkinson’s disease Nervous system > Diseases. Molecular neurobiology.
Linkit:	http://hdl.handle.net/10361/23932

Samankaltaisia teoksia

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
Tekijä: Dey, Manashi
Julkaistu: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
Tekijä: Halim, Rabea
Julkaistu: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
Tekijä: Zaman, Rubaiyat
Julkaistu: (2024)

Targeting circular RNA for cardiovascular diseases
Tekijä: Sarkar, Deepannita
Julkaistu: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
Tekijä: Bakar, Osama Bin Abu
Julkaistu: (2024)

RNA drugs and RNA targets for small molecules: Prospects and challenges
Tekijä: Islam, Md. Raihanul
Julkaistu: (2024)

Implications of unusual non-coding RNAs in human diseases
Tekijä: Ahmed, Tazkia
Julkaistu: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
Tekijä: Mostofa, Golam
Julkaistu: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
Tekijä: Chowdhury, Sariya Uzrat
Julkaistu: (2022)

A review on optogenetics and its potential in neurological disorder management
Tekijä: Armin, Fariza
Julkaistu: (2024)

A computational approach to design putative potential siRNAs for silencing the nucleoprotein and surface glycoprotein gene of MARV
Tekijä: Suraiya, Tasnia Iffat
Julkaistu: (2023)

Gene editing for neurodegenerative diseases-A review
Tekijä: Sharna, Anika Islam
Julkaistu: (2023)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
Tekijä: Ferdous, Labiba
Julkaistu: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Tekijä: Alim, Abdul
Julkaistu: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
Tekijä: Annee, Israt Jahan
Julkaistu: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
Tekijä: Tasneem, Sadia
Julkaistu: (2021)

A review paper on developing novel antiviral strategies against pathogenic RNA viruses
Tekijä: Nawar, Numia
Julkaistu: (2021)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Tekijä: Tabassum, Nadira
Julkaistu: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
Tekijä: Afsana, Nourin
Julkaistu: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
Tekijä: Islam, Md. Irfath
Julkaistu: (2023)

Unlocking the therapeutic potential of RNA: a comprehensive review of RNA-based therapy
Tekijä: Ahmad, Rafid Uddin, et al.
Julkaistu: (2024)

Role of voltage-gated sodium channel modulators in peripheral nervous system disorders
Tekijä: Mithila, Sabekun Nahar
Julkaistu: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
Tekijä: Shehab, Habibul Mohsin
Julkaistu: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
Tekijä: Mahaleka, Aarshi
Julkaistu: (2024)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
Tekijä: Aziz, Farhin
Julkaistu: (2019)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
Tekijä: Islam, Md. Rakibul
Julkaistu: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
Tekijä: Karmaker, Swastika
Julkaistu: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
Tekijä: Key, Nasrin Sultana
Julkaistu: (2023)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
Tekijä: Rawshan, A. E. Maisha
Julkaistu: (2022)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
Tekijä: Ishrat, Nowshin
Julkaistu: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
Tekijä: Saha, Bithi Rani
Julkaistu: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
Tekijä: Chowdhury, Amal
Julkaistu: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
Tekijä: Afreen, Nuraia
Julkaistu: (2021)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
Tekijä: Hassan, Md. Muhtaz
Julkaistu: (2020)

A review on the role of Myc and miRNA in Glioblastoma multiforme
Tekijä: Naureen, Ishrat
Julkaistu: (2022)

Review on: the mechanism and function of Glia in parkinson's disease
Tekijä: Abedin, Khondokar Mezbahul
Julkaistu: (2023)

Alzheimer's disease and marriage : an intimate account /
Tekijä: Wright, Lore K.
Julkaistu: (1993)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
Tekijä: Tamanna, Mst. Taskia
Julkaistu: (2023)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
Tekijä: Nuha, Nabiha Tahsin
Julkaistu: (2024)

Detection of Parkinson’s disease from Neuro-imagery using deep neural network with transfer learning
Tekijä: Asaduzzaman, et al.
Julkaistu: (2021)